Radiation boosts immunotherapy in advanced cancer trial
NCT ID NCT02843165
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 23 times
Summary
This study looked at whether adding targeted radiation (SBRT) to standard immunotherapy can improve tumor shrinkage in people with advanced cancer that has spread. About 106 participants received either immunotherapy alone or combined with radiation. The goal was to see if the combination leads to better response rates and how safe the treatment is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.